Triptolide promotes spinal cord repair by inhibiting astrogliosis and inflammation

GLIA

Volumn 58, Issue 8, 2010, Pages 901-915

  Su, Zhida ^a   Yuan, Yimin ^a   Cao, Li ^a   Zhu, Yanling ^a   Gao, Liang ^a   Qiu, Yang ^a   He, Cheng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Astrogliosis; Axon regeneration; Glial scar; Inflammation; Spinal cord injury; Triptolide

Indexed keywords

CD11B ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; JANUS KINASE 2; STAT3 PROTEIN; TRIPTOLIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CHINESE HERB; CONTROLLED STUDY; GLIA; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; LOCOMOTION; MALE; NERVE FIBER REGENERATION; NEUROFILAMENT; NEWBORN; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; SCAR; SPINAL CORD INJURY; STAINING; TRIPTERYGIUM WILFORDII;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DITERPENES; EPOXY COMPOUNDS; EXPLORATORY BEHAVIOR; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; JANUS KINASE 2; MALE; NEUROFILAMENT PROTEINS; PHENANTHRENES; PSYCHOMOTOR PERFORMANCE; PYRAMIDAL TRACTS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SPINAL CORD INJURIES; STAT3 TRANSCRIPTION FACTOR;

EID: 77952576395     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20972     Document Type: Article

References (44)

1. Basso DM, Beattie MS, Bresnahan JC. 1995. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12:1-21.
2. Bethea JR. 2000. Spinal cord injury-induced inflammation: A dualedged sword. Prog Brain Res 128:33-42.
3. Cao L, Zhu Y, Su Z, Lv B, Huang Z, Mu L, He C. 2007. Olfactory ensheathing cells promote migration of Schwann cells by secreted nerve growth factor. Glia 55:897-904.
4. Chen BJ. 2001. Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F. Leuk Lymphoma 42:253-265.
5. Cuzzocrea S, Genovese T, Mazzon E, Esposito E, Di Paola R, Muià C, Crisafulli C, Peli A, Bramanti P, Chaudry IH. 2008. Effect of 17betaestradiol on signal transduction pathways and secondary damage in experimental spinal cord trauma. Shock 29:362-371.
6. Eliasson C, Sahlgren C, Berthold CH, Stakeberg J, Celis JE, Betsholtz C, Eriksson JE, Pekny M. 1999. Intermediate filament protein partnership in astrocytes. J Biol Chem 274:3996-4006.
7. Fitch MT, Silver J. 2008. CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp Neurol 209:294-301.
8. Fleming JC, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, Saenz AD, Pasquale-Styles M, Dietrich WD, Weaver LC. 2006. The cellular inflammatory response in human spinal cords after injury. Brain 129:3249-3269.
9. Goldshmit Y, Galea MP, Wise G, Bartlett PF, Turnley AM. 2004. Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice. J Neurosci 24:10064-10073.
10. Gris D, Marsh DR, Oatway MA, Chen Y, Hamilton EF, Dekaban GA, Weaver LC. 2004. Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function. J Neurosci 24:4043-4051.
11. Herrmann JE, Imura T, Song B, Qi J, Ao Y, Nguyen TK, Korsak RA, Takeda K, Akira S, Sofroniew MV. 2008. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci 28:7231-7243.
12. Hirano K, Ichikawa T, Nakao K, Matsumoto A, Miyaaki H, Shibata H, Eguchi S, Takatsuki M, Ikeda M, Yamasaki H, Kato N, Kanematsu T, Ishii N, Eguchi K. 2008. Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin A, on interferon-induced antiviral protein in human hepatocyte cells. Liver Transplant 14:292-298.
13. Jones LL, Margolis RU, Tuszynski MH. 2003. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp Neurol 182:399-411.
14. Justicia C, Gabriel C, Planas AM. 2000. Activation of the JAK/STAT pathway following transient focal cerebral ischemia: Signaling through jak1 and stat3 in astrocytes. Glia 30:253-270.
15. Kaminska B, Pyrzynska B, Figiel I, Lis A, Dziembowska M, Mosieniak G. 2000. The effects of cyclosporin A on glial and neuronal cells in vitro-looking for CsA targets. In: Gold, Fischer, Herdegen, editors. Immunophilin-ligands as a novel treatment in neurodegenerative disorders. Prous Science. p 189-197.
16. Karimi-Abdolrezaee S, Eftekharpour E, Wang J, Morshead CM, Fehlings MG. 2006. Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J Neurosci 26:3377-3389.
17. Kiviharju TM, Lecane PS, Sellers RG, Peehl DM. 2002. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin Cancer Res 8:2666-2674.
18. Leuenroth SJ, Crews CM. 2005. Studies on calcium dependence reveal multiple modes of action for triptolide. Chem Biol 12:1259-1268.
19. Leuenroth SJ, Crews CM. 2008. Triptolide-induced transcriptional arrest is associated with changes in nuclear substructure. Cancer Res 68:5257-5266.
20. Liu J, Farmer JD Jr., Lane WS, Friedman J, Weissman I, Schreiber SL. 1991. Calcineurin is a common target of cyclophilin-cyclosporin A, FKBP-FK506 complexes. Cell 66:807-815. (Pubitemid 121001714)
21. Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K, Yamane J, Yoshimura A, Iwamoto Y, Toyama Y, Okano H. 2006. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 12:829-834. (Pubitemid 44050074)
22. Pekny M, Nilsson M. 2005. Astrocyte activation and reactive gliosis. Glia 50:427-434.
23. Qiu D, Kao PN. 2003. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs R D 4:1-18.
24. Qiu D, Zhao G, Aoki Y, Shi L, Uyei A, Nazarian S, Ng JC, Kao PN. 1999. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation. J Biol Chem 274:13443-13450. (Pubitemid 129518557)
25. Ridet JL, Malhotra SK, Privat A, Gage FH. 1997. Reactive astrocytes: Cellular and molecular cues to biological function. Trends Neurosci 20:570-577. (Pubitemid 27508969)
26. Rolls A, Shechter R, Schwartz M. 2009. The bright side of the glial scar in CNS repair. Nat Rev Neurosci 10:235-241.
27. Ruitenberg MJ, Levison DB, Lee SV, Verhaagen J, Harvey AR, Plant GW. 2005. NT-3 expression from engineered olfactory ensheathing glia promotes spinal sparing and regeneration. Brain 128:839-853. (Pubitemid 40516921)
28. Schnell L, Fearn S, Klassen H, Schwab ME, Perry VH. 1999. Acute inflammatory responses to mechanical lesions in the CNS: Differences between brain and spinal cord. Eur J Neurosci 11:3648-3658.
29. Schubert KO, Naumann T, Schnell O, Zhi Q, Steup A, Hofmann HD, Kirsch M. 2005. Activation of STAT3 signaling in axotomized neurons and reactive astrocytes after fimbria-fornix transaction. Exp Brain Res 165:520-531.
30. Sriram K, Benkovic SA, Hebert MA, Miller DB, O'Callaghan JP. 2004. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration. J Bio Chem 279:19936-19947.
31. Stoll G, Jander S, Schroeter M. 2002. Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Adv Exp Med Biol 513:87-113. (Pubitemid 36332404)
32. Su Z, Cao L, Zhu Y, Liu X, Huang Z, Huang A, He C. 2007. Nogo enhances the adhesion of olfactory ensheathing cells and inhibits their migration. J Cell Sci 120:1877-1887.
33. Tederko P, Krasuski M, Kiwerski J, Nyka I, Bia[swsl]loszewski D. 2009. Strategies for neuroprotection following spinal cord injury. Ortop Traumatol Rehabil 11:103-110.
34. Tian DS, Dong Q, Pan DJ, He Y, Yu ZY, Xie MJ, Wang W. 2007. Attenuation of astrogliosis by suppressing of microglial proliferation with the cell cycle inhibitor olomoucine in rat spinal cord injury model. Brain Res 1154:206-214.
35. Tian DS, Liu JL, Xie MJ, Zhan Y, Qu WS, Yu ZY, Tang ZP, Pan DJ, Wang W. 2009. Tamoxifen attenuates inflammatory-mediated damage and improves functional outcome after spinal cord injury in rats. J Neurochem 109:1658-1667.
36. Tian DS, Yu ZY, Xie MJ, Bu BT, Witte OW, Wang W. 2006. Suppression of astroglial scar formation and enhanced axonal regeneration associated with functional recovery in a spinal cord injury rat model by the cell cycle inhibitor olomoucine. J Neurosci Res 84:1053-1063.
37. Wilhelmsson U, Li L, Pekna M, Berthold CH, Blom S, Eliasson C, Renner O, Bushong E, Ellisman M, Morgan TE, Pekny M. 2004. Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration. J Neurosci 24:5016-5021.
38. Wu Y, Wang Y, Zhong C, Li Y, Li X, Sun B. 2003. The suppressive effect of triptolide on experimental autoimmune uveoretinitis by down-regulating Th1-type response. Int Immunopharmacol 3:1457-1465.
39. Xue B, Jiao J, Zhang L, Li KR, Gong YT, Xie JX, Wang XM. 2007. Triptolide upregulates NGF synthesis in rat astrocyte cultures. Neurochem Res 32:1113-1119.
40. Yan H, Rivkees SA. 2002. Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells. J Neurosci Res 69:597-606.
41. Yiu G, He ZG. 2006. Glial inhibition of CNS axon regeneration. Nat Rev Neurosci 7:617-627.
42. Yu ACH, Lee YL, Eng LF. 1993. Astrogliosis in culture. I. The model and the effect of antisense oligonucleotides on glial fibrillary acidic protein synthesis. J Neurosci Res 34:295-303.
43. Zhou HF, Liu XY, Niu DB, Li FQ, He QH, Wang XM. 2005. Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection. Neurobiol Dis 18:441-449.
44. Zhou HF, Niu DB, Xue B, Li FQ, Liu XY, He QH, Wang XH, Wang XM. 2003. Triptolide inhibits TNF-a, IL-1b and NO production in primary microglial cultures. Neuroreport 14:1091-1095. (Pubitemid 36829797)